WallStreetZenWallStreetZen

NASDAQ: CYCC
Cyclacel Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CYCC past revenue growth

How has CYCC's revenue growth performed historically?
Company
N/A
Industry
148.4%
Market
16.96%
CYCC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CYCC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

CYCC earnings and revenue history

Current Revenue
$420.0k
Current Earnings
-$22.8M
Current Profit Margin
-5,418.1%

CYCC Return on Equity

Current Company
-450.9%
Current Industry
-63.5%
Current Market
188%
CYCC's Return on Equity (-450.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CYCC announces earnings.

CYCC Return on Assets

Current Company
-152.2%
Current Industry
2.9%
CYCC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CYCC Return on Capital Employed

Current Company
-3,967.55%
Current Industry
19.5%
CYCC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CYCC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CYCC$420.00k-$25.52M-$22.76M+22.87%N/A
PHIO$0.00-$10.64M-$10.83M-100.00%N/A
SXTP$253.57k-$1.38M-$3.92M-95.20%N/A
ONCO$58.47k-$36.71M-$37.41MN/AN/A
GOVX$0.00-$25.89M-$25.97M-100.00%N/A
View Top Biotech Stocks

CYCC earnings dates

Next earnings date
May 9, 2024

Cyclacel Pharmaceuticals Earnings & Revenue FAQ

What were CYCC's earnings last quarter?

On Invalid Date, Cyclacel Pharmaceuticals (NASDAQ: CYCC) reported Q4 2023 earnings per share (EPS) of -$5.96, up 35.01% year over year. Total Cyclacel Pharmaceuticals earnings for the quarter were -$5.32 million. In the same quarter last year, Cyclacel Pharmaceuticals's earnings per share (EPS) was -$9.17.

If you're new to stock investing, here's how to buy Cyclacel Pharmaceuticals stock.

What was CYCC's earnings growth in the past year?

As of Q2 2024, Cyclacel Pharmaceuticals's earnings has grown year over year. Cyclacel Pharmaceuticals's earnings in the past year totalled -$22.76 million.

What is CYCC's earnings date?

Cyclacel Pharmaceuticals's earnings date is Invalid Date. Add CYCC to your watchlist to be reminded of CYCC's next earnings announcement.

What was CYCC's revenue last quarter?

On Invalid Date, Cyclacel Pharmaceuticals (NASDAQ: CYCC) reported Q4 2023 revenue of $31.00 thousand up Infinity% year over year. In the same quarter last year, Cyclacel Pharmaceuticals's revenue was $0.00.

What was CYCC's revenue growth in the past year?

As of Q2 2024, Cyclacel Pharmaceuticals's revenue has grown null year over year. Cyclacel Pharmaceuticals's revenue in the past year totalled $420.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.